Key result
Azithromycin prophylaxis reduces postpartum readmissions or unexpected visits by ~40%.
Why the study?
Hospital readmissions and unexpected visits after cesarean delivery are increasingly tracked for value-based compensation, but incidence and risk factors remain to be determined.
Does adjunctive azithromycin prophylaxis reduce hospital readmission or unexpected visits in women undergoing unscheduled cesarean delivery?
RCT (n=2,013)
Placebo-controlled
Randomized
Yes
Does adjunctive azithromycin prophylaxis reduce hospital readmission or unexpected visits in women undergoing unscheduled cesarean delivery?
In women undergoing unscheduled cesarean delivery, adjunctive azithromycin prophylaxis reduces the risk of postpartum readmissions and unexpected visits, whereas diabetes, prolonged ruptured membranes, and postpartum fever increase the risk.
Answers are grounded in this paper and cite their sources.
Azithromycin prophylaxis was associated with fewer readmissions after unscheduled cesarean; hypothesis-generating and requires randomized confirmation before practice change.
OBJECTIVE: Hospital readmissions are increasingly tracked and assessed for value-based compensation. Our objective was to determine the incidence and risk factors associated with post-cesarean delivery (CD) readmissions or unexpected visits, defined as unexpected office or emergency room visits. STUDY DESIGN: This is a secondary analysis of a multicenter randomized controlled trial of adjunctive azithromycin prophylaxis for CD performed in laboring patients with viable pregnancies. Patients were followed up to 6 weeks postpartum. Our primary outcome was a composite of hospital readmission or unexpected visit, defined as unscheduled clinic or emergency department visits. Data of hospital readmissions, unexpected visits, and their reasons were collected. Demographics, antepartum, intrapartum, and postpartum risk factors were evaluated in bivariate analyses and multivariable logistic regression modeling. RESULTS: A total of 1,019 women were randomized to azithromycin and 994 to placebo. The prevalence of readmission or unexpected visit was 10.2% (95% confidence interval [CI]: 8.9-11.6), with rates of 3.8% (95% CI: 3.0-4.7%) hospital readmissions, 6.9% (95% CI: 5.8-8.0%) emergency room visits, and 4.2% (95% CI: 3.4-5.2%) unexpected clinic visits. The most common causes were infectious disease and hypertensive disorder. Women with readmissions or unexpected visits were more likely to be obese and diabetic, as well as experience longer length of ruptured membranes, intrauterine pressure catheter placement, and postpartum fevers. On multivariable analysis, diabetes (adjusted odds ratio [aOR]: 1.6, 95% CI: 1.1-2.4), prolonged ruptured membranes (aOR: 1.9, 95% CI: 1.3-2.8), and postpartum fevers (aOR: 4.6, 95% CI: 3.0-7.0) were significantly positively associated with readmission or unscheduled visit, while azithromycin was a protective (aOR: 0.6, 95% CI: 0.5-0.9). CONCLUSION: Women who had postpartum fever were at especially high risk for readmission or unexpected visits. Diabetes, prolonged ruptured membranes, and postpartum fevers were significantly associated with the adverse outcome, and azithromycin was associated with lower rates of readmission and unexpected visits.
No takes yet. Share an insight, caveat, or question.
Rosa et al. (2019) conducted an RCT in Unscheduled cesarean delivery (n=2,013). Adjunctive azithromycin prophylaxis vs. Placebo was evaluated on Composite of hospital readmission or unexpected visit (unscheduled clinic or emergency department visits) (aOR 0.6, 95% CI 0.5-0.9). Postpartum fever, prolonged ruptured membranes, and diabetes increased the risk of readmission or unexpected visits, whereas azithromycin prophylaxis was protective (aOR 0.6; 95% CI 0.5-0.9).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: